Indeed, the principal obstacle for therapies against GBM resulted to be the BBB, a highly specialized non‐fenestrated physical barrier formed by microvascular endothelial cells interconnected by multi‐protein tight junctions consisting of claudins, occludins and junctional adhesion molecules [52]. The gene discussed is OCLN; the disease is glioblastoma.